IP Library Granted Patent US 8,431,770
Granted Patent B2
US 8,431,770 · App. 12/319,396 · Granted Apr 30, 2013

Method of producing sialytransferase-modified proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,431,770
App. No.
12/319,396
Granted
Apr 30, 2013
Kind
B2
Abstract

Transgenic avians which produce proteins in their oviduct tissue having modified oligosaccharide structures and methods of making such avians are disclosed herein. The invention also includes the modified proteins produced in the transgenic birds.

Claims (11)

1. A method of producing an isolated protein modified by sialyltransferase using a transgenic chicken, the method comprising:

a) producing a transgenic chicken containing a transgene encoding sialyltransferase operably linked to an oviduct-specific promoter, wherein the sialyltransferase is expressed in oviduct tissue of the chicken, and wherein the sialyltransferase adds terminal sialic acid on oligosaccharides of proteins in oviduct tissue of the chicken; and

b) isolating protein with additional terminal sialic acid on oligosaccharides from egg white of the transgenic chicken.

2. The method of claim 1 wherein the sialyltransferase is sialyltransferase type 1, 2, 3, 4, 5 or 6.

3. The method of claim 1 wherein the protein is produced in tubular gland cells.

4. The method of claim 1 wherein the oligosaccharide comprises 1 to 5 sialic acids.

5. The method of claim 1 wherein the oviduct specific promoter is an ovalbumin promoter.

6. The method of claim 1 wherein the oviduct specific promoter is an ovomucoid promoter.

7. The method of claim 2 wherein the sialyltransferase is sialyltransferase type 2.

8. The method of claim 2 wherein the sialyltransferase is sialyltransferase type 3.

9. The method of claim 2 wherein the sialyltransferase is sialyltransferase type 6.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2016
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 039934/0687 →
MERGER AND CHANGE OF NAME Recorded Jun 17, 2016
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 038939/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2009
From: HARVEY, ALEX J.
To: SYNAGEVA BIOPHARMA CORP.
Reel/Frame 022226/0330 →